Prev Chronic Dis by Wohler, Brad et al.
PREVENTING  CHRONIC  DISEASE
P U B L I C  H E A L T H  R E S E A R C H ,  P R A C T I C E ,  A N D  P O L I C Y 





Using the National Death Index to Identify
Duplicate Cancer Incident Cases in Florida
and New York, 1996–2005
 
Brad Wohler, MS; Baozhen Qiao, PhD; Hannah K. Weir, PhD; Jill A. MacKinnon, PhD;
Maria J. Schymura, PhD 
 
Suggested citation for this article: Wohler B, Qiao B, Weir HK,
MacKinnon JA, Schymura MJ. Using the National Death Index to
Identify  Duplicate  Cancer  Incident  Cases  in  Florida  and New





Cancer registries link incidence data to state death certificates to
update vital status and identify missing cases; they also link these
data  to  the  National  Death  Index (NDI)  to  update  vital  status
among patients  who leave the state  after  their  diagnosis.  This
study explored the use of information from NDI linkages to identi-
fy potential duplicate cancer cases registered in both Florida and
New York.
Methods
The Florida Cancer Data System (FCDS) and the New York State
Cancer Registry (NYSCR) linked incidence data with state and
NDI death records from 1996 through 2005. Information for pa-
tients whose death occurred in the reciprocal state (the death state)
was exchanged. Potential duplicate cases were those that had the
same diagnosis and the same or similar diagnosis date.
Results
NDI identified 4,657 FCDS cancer patients who died in New York
and 2,740 NYSCR cancer patients who died in Florida. Matching
identified 5,030 cases registered in both states; 508 were death
certificate-only (DCO) cases  in  the  death state’s  registry,  and
3,760 (74.8%) were potential duplicates. Among FCDS and NY-
SCR patients who died and were registered in the registry of the
reciprocal state, more than 50% were registered with the same
cancer diagnosis, and approximately 80% had similar diagnosis
dates (within 1 year).
Conclusion
NDI identified DCO cases in the death state’s cancer registry and
a  large  proportion  of  potential  duplicate  cases.  Standards  are
needed for assigning primary residence when multiple registries
report  the  same  case.  The  registry  initiating  the  NDI  linkage
should consider sharing relevant information with death state re-
gistries so that these registries can remove erroneous DCO cases
from their databases.
Introduction
In the United States, there is a population-based cancer registry in
all 50 states, Puerto Rico, the US Pacific Island jurisdictions, the
District of Columbia, and 6 metropolitan areas funded by the Cen-
ters for Disease Control and Prevention’s (CDC’s) National Pro-
gram of Cancer Registries (NPCR) and/or the National Cancer In-
stitute’s (NCI’s) Surveillance, Epidemiology, and End Results
(SEER) Program. Registries collect information on all residents
newly diagnosed with or  treated for  cancer in their  catchment
areas and report de-identified data to their federal surveillance pro-
grams and to the North American Association of Central Cancer
Registries (NAACCR), where the data are combined for the pur-
pose of reporting national, regional, and state cancer incidence
data (1–4).
Cancer registries collect data using procedures and codes promul-
gated by NAACCR (5), including personal and demographic data
(eg, name, social security number, birth date, race/ethnicity, sex,
residence  at  diagnosis)  and  case  data  (eg,  date  of  diagnosis,
primary site,  histology, behavior).  Cancer patients can be dia-
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gnosed with multiple primary cancers; therefore, each cancer case
is assigned a sequence number according to the temporal order in
which it was diagnosed. Registries also collect follow-up informa-
tion, including data on vital status (alive or dead), date of last con-
tact, and cause of death.
Deaths are recorded by the vital records office in the state where
the death occurred, and if applicable, the death certificate is for-
warded, per data-exchange agreement, to the vital records office in
the state where the person resided at the time of death. Each year,
cancer registries perform death clearance (6), the process by which
registries link their incidence data with their state death certific-
ates to identify cancer patients who may have been missed by the
registry at the time of their diagnosis and to update vital status
(deaths) among registered cancer patients. If no information is
found in the registry for a cancer diagnosis on these death certific-
ate–initiated cases, they are registered as death certificate–only
(DCO) cases in the cancer registry’s database.
However, patients may move out of state between the time of their
diagnosis and their death. When an incident record does not match
with a state death certificate record, the cancer registry may send
patient personal and demographic data for linkage with CDC’s
National Death Index (NDI) (7). The NDI is a repository of death
certificate information from vital statistics offices in all 50 states,
the District  of  Columbia,  and Puerto Rico.  To encourage NDI
linkages, CDC and NCI have arranged for NDI linkage services to
be available at no cost to the registries.
An accurate count of incident cases is necessary for understand-
ing the burden of cancer in the population and for planning health
resources to meet the growing cancer burden. However, the data
that are reported to the federal surveillance programs do not con-
tain personal identifiers and, therefore, it is not possible to identi-
fy duplicate cases — incident cases that have the same diagnosis
and similar diagnosis dates and are reported by 2 or more cancer
registries. Duplicate case reporting can lead to over-counting in-
cident cases and create an inaccurate picture of the cancer burden
at the state and national levels.
The Florida Cancer Data System (FCDS) and the New York State
Cancer Registry (NYSCR) routinely perform death clearance with
their state death certificate records, and both have sent personal
and demographic data on incident cases to NDI. The objective of
this study was to explore the use of information from NDI link-
ages to identify potential duplicate cancer cases registered in both
the FCDS and the NYSCR.
Methods
Source of data
The FCDS began as a population-based cancer registry in 1981
and received funding from NPCR for the reporting of incidence
data  beginning  in  1995.  The  FCDS  registers  approximately
100,000 new incident cases per year. The NYSCR has been popu-
lation-based since 1976 and received funding from NPCR for the
reporting of incidence data beginning in 1996. The NYSCR re-
gisters approximately 100,000 new incident cases per year. Both
registries conduct annual death clearance and in 2008, both regis-
tries sent data to NDI for linkage to information on deaths that oc-
curred through December 31, 2005.
Per agreement with NCHS, the registry that initiates the NDI link-
age  may  share  NDI-derived  information  (except  for  cause  of
death) with the cancer registry in the state where the death oc-
curred (death state) to determine whether the cancer patient was
registered in that state’s cancer registry. Both FCDS and NYSCR
have agreements that allow for the exchange of data between the 2
registries.
Common procedures were used to prepare data for linkage with
NDI and process linkage results (8). FCDS staff identified deaths
in New York among cancer patients registered in the FCDS; con-
versely, NYSCR staff identified deaths in Florida among cancer
patients registered in the NYSCR. Exchange files were prepared
by each registry; the files included personal and demographic in-
formation (name, birth date, social security number, sex, and race/
ethnicity), case information (diagnosis date, primary site, histo-
logy, behavior, laterality, sequence number, and type of reporting
source), and data from the NDI linkages (death date, death certific-
ate number).  Each record included a 5-digit  SEER site recode,
which was assigned on the basis of information on primary site
and histology (9). When a patient had multiple cancer diagnoses,
information on all cases was included in the exchange files.
Data linkage and analysis
We examined linkage between the FCDS and NYSCR and their
state death certificate records and the NDI for deaths from 1996
through 2005 among cancer cases diagnosed during the same peri-
od. Exchange files were matched to the cancer registry database
by using algorithms developed by the registry.  If  a match was
found, further comparisons were made, including whether the in-
cident case was registered as a single primary (ie, only) cancer or
one of multiple primary cancers, whether the case was registered
as a DCO case in the death state registry, and whether the SEER
site codes matched. If the match was not a DCO case, and if the
first 4 digits of the SEER site recode were the same, the diagnosis
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dates were compared for Florida residents who died in New York
and were registered in the NYSCR and for New York residents
who died in Florida and were registered in the FCDS.
Results
In Florida, 997,290 cancer cases were diagnosed among Florida
residents and registered in the FCDS (Table 1). During the same
period, 434,526 deaths were reported among these cancer patients.
Linkage with state death certificate records identified 398,196
(91.6%) deaths, all of which occurred in Florida, and linkage with
NDI identified 36,330 (8.4%) additional  deaths.  Among NDI-
identified deaths, 3,464 occurred in Florida and 32,866 occurred
outside of Florida; 4,657 of these occurred in New York.
In New York, 952,663 cancer cases were diagnosed among New
York residents and registered in the NYSCR (Table 1). During the
same period, 401,463 deaths were reported among these patients.
Linkage with state death certificate records identified 389,164
(96.9%) deaths;  of  these,  383,343 occurred  in  New York and
5,821 occurred outside of the state; approximately 26% occurred
in Florida. Linkage with NDI identified 12,299 (3.1%) additional
deaths.  Among NDI-identified deaths,  1,398 occurred in  New
York and 10,901 deaths occurred outside of New York; 2,740
(25%) deaths occurred in Florida.
Of the 2,740 patients who were registered in the NYSCR and died
in Florida, 66.0% (1,808/2,740) matched to a patient in the FCDS
database (Table 2). Among matched patients, 15.2% (275/1,808)
were registered as a single primary DCO case and 69.0% (1,248/
1,808) were registered with at least 1 record indicating the same
diagnosis site reported by the NYSCR.
Of the 4,657 patients who were registered in the FCDS and died in
New York, 69.2% (3,222/4,657) matched to a patient in the NY-
SCR database (Table 2). Among matched patients, 7.2% (233/
3,222) were registered as a single primary DCO case and 78.0%
(2,512/3,222) were registered with at least 1 record indicating the
same diagnosis site reported by FCDS.
Of the 3,760 patients registered in both the FCDS and NYSCR,
4,035  potential  duplicate  cancer  cases  were  identified:  948
(23.5%) lung and bronchus, 472 (11.7%) colorectal, 373 (9.2%)
female breast cancer, 358 (8.9%) prostate cancer, 266 (6.7%) urin-
ary bladder, and 1,618 (40.1%) other cancers (Table 3). Among
matched cases, the difference between the diagnosis dates was 6
months or less for 73.7% of cases, 1 year or less for 81.7% of
cases, and more than 2 years for 12.3% of cases; and 72.2% of all
matched cases were reported as a single primary case in the can-
cer registry.
Discussion
This study provides evidence that cancer patients were registered
in both the FCDS and the NYSCR, and that linkage with the NDI
identified DCO cases that could be removed from the registry in
the state where the death occurred. NDI linkages also identified
potential duplicate cancer cases. Procedures are needed for de-
termining residence at diagnosis for cancer patients registered in
more than one cancer registry with the same or related diagnosis.
As in previous findings (10), linkage with state death certificates
identified the majority of deaths among deceased cancer patients
registered in the FCDS (91.6%) and the NYSCR (96.9%), where-
as linkage with the NDI identified additional deaths among pa-
tients who died in the state where they were registered and deaths
that occurred in a different state.
NDI identified  deaths  that  were  missed through routine  death
clearance for several possible reasons. First, death clearance is
usually performed once per death year and near the end of the dia-
gnosis year. If an incident record or death certificate is reported
late to the registry or vital records offices, the record or certificate
may not be available at the time of death clearance. Second, the
matching algorithms used by the registries differ from those used
by NDI; the former uses probabilistic linkages while the latter uses
multiple deterministic linkages (11), and deaths may be missed by
one or the other.  However,  a  side-by-side comparison of state
(probabilistic) and NDI (deterministic) linkage results using Geor-
gia incidence and death data yielded similar results (K. C. Ward,
PhD, MPH, Georgia Center for Cancer Statistics, personal com-
munication), so this difference in algorithms probably does not ex-
plain the missing deaths. Third, some data-exchange agreements,
such as those with the Florida vital records office, may limit the
use of exchanged death certificate information to statistical report-
ing. As a result, the FCDS was missing information on nearly 1%
of deceased cancer patients who died out of state and whose death
certificates were not shared with the FCDS. Fourth, death clear-
ance is used to ascertain missing incident cases, and registry staff
may use only cancer-related deaths to expedite the process. If a pa-
tient did not die from cancer, the death would be missed.
In this study, most NDI matches were for deaths that occurred
among cancer patients who were diagnosed in one state (the dia-
gnosis state) and moved and died as a resident of a different state
(the death state). Because the death occurred to a resident of a dif-
ferent state, the cancer registry in the diagnosis state would have
no knowledge of the death if the registry relies on linkage with
state death certificate records to ascertain deaths.
PREVENTING CHRONIC DISEASE VOLUME 11, E167
PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY SEPTEMBER 2014
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services,
the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions.
www.cdc.gov/pcd/issues/2014/14_0200.htm • Centers for Disease Control and Prevention       3
Most cancer patients who died in a different state than the one in
which they were presumably diagnosed were also registered as in-
cident cases in the death state’s cancer registry. Among the 4,657
FCDS patients  who  died  in  New York  State,  69.2% were  re-
gistered in the NYSCR and of the 2,740 NYSCR patients who
died in Florida, 66.0% were registered in the FCDS. A small num-
ber of these patients (233 in the NYSCR and 275 in the FCDS)
were reported as DCO cases in the death state’s cancer registry.
These cases could be removed from the registry regardless of their
cause of death because the cancer was diagnosed while the patient
was a resident in a different state. Death certificates do not always
accurately reflect  the true cause of death (12,13);  therefore,  it
seems reasonable to remove these cases regardless of agreement
between the coded cause of death and the coded cancer at diagnos-
is.
Recently, the FCDS and the NYSCR sent data on incident cases
spanning their complete years of operations to NDI and conduc-
ted data exchange with a focus on removing erroneous DCO cases.
Through this process, 1,300 additional DCO cases were removed
from  the  NYSCR  database  (B.Q.,  unpublished  data,  2012).
However, this process left numerous potential duplicate cases that
were registered as non-DCO incident cases. Of these, most were
registered in the other state’s cancer registry with the same dia-
gnosis in both registries. Most of these cases were reported as a
single primary cancer in both registries and had similar diagnosis
dates. Further investigation is needed to resolve these potential du-
plicate case reports. To resolve these cases, it will be necessary to
develop procedures to determine usual residence at diagnosis (5).
For example, a cancer patient may reside in more than one state
during the year, spending winter months in a southern state, such
as Florida, and summer months in a northern state, such as New
York. For the purpose of being enumerated by the US Census,
only one usual residence is recognized (14). If similar rules were
adopted  by  cancer  registries,  it  might  help  ensure  agreement
between the numerator (incident cases) and the denominator (pop-
ulation counts) when calculating cancer incidence rates.
Information on patients who are diagnosed or treated for cancer,
regardless of where they reside, is required by public law (15) to
be reported to the cancer registry in the state where the medical
services are performed. The registry then sends this information to
the cancer registry in the state where the patient resides, provided
the patient’s correct residence is known and data-exchange agree-
ments are in place. This scenario is complicated when a cancer pa-
tient changes residence in the middle of care, for example, to be
closer to family and friends. Without querying the cancer patient
directly, it may be difficult to identify the original place of resid-
ence.
The issue of duplicate case reporting within cancer registries is
well recognized (16,17). NAACCR has standards for reporting
high-quality cancer incidence data, which include the requirement
that registries have one or fewer duplicate cases per 1,000 cases
reported  (18).  However,  the  issue  of  duplicate  case  reporting
between and among registries has, to our knowledge, not been
raised.
Cancer registries in Australia (19), Canada (20), Sweden (21), and
the United Kingdom (22) routinely report personal identifiers as
well as demographic and case data to their national cancer surveil-
lance organizations. For example, the Canadian Cancer Registry
(CCR) is a patient-based system maintained by Statistics Canada
(20). The 13 provincial and territorial cancer registries annually re-
port data to the CCR, which conducts internal record linkages to
detect duplicate records and match incidence records to death re-
cords in its national mortality database (23). Conflicting informa-
tion and duplicate case reports are resolved through consultation
with the provincial and territorial cancer registries that reported
the information. In addition, the CCR identifies multiple primary
cancers in a cancer patient when the first primary cancer is dia-
gnosed in one province or territory and the subsequent primary
cancer is diagnosed in another.
Unlike Canada and elsewhere, the 2 US cancer surveillance sys-
tems (NPCR and SEER) are primarily case-based systems. Be-
cause NPCR and SEER registries do not report personal identifi-
ers to their surveillance programs, identifying inter-registry du-
plicate case reports or multiple primary cancer cases registered in
the same patient but in different cancer registries is not possible.
Although the total number of potential duplicate cases identified in
this study was less than 1% of all incident cases in both the FCDS
and the NYSCR, the finding that most deceased cancer patients
whose deaths were reported in both the FCDS and the NYSCR
had the same cancer site (and of these, a similar date of diagnosis)
suggests that the impact of duplicate case reporting could be much
higher if linkages were extended to include living cancer patients
and were performed among cancer registries in the United States.
Many US registries operate in small geographic areas and in popu-
lation centers close to bordering states (Figure). The challenges
posed by inter-registry duplicate cases among cancer registries in
the United States are likely to increase: the number of annual can-
cer incident cases is projected to double from 2000 to 2050 (24);
the US population is mobile (25); and cancer patients are living
longer after diagnosis (2,26).
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Figure. State, territory, and metropolitan-area cancer registries participating in
the National Program of Cancer Registries or the Surveillance, Epidemiology,
and End Results programs or both programs as of 2000. Source: US Cancer
Statistics Working Group (27).
 
NDI identified DCO cases that were, but should not have been, re-
gistered in the death state’s cancer registry. Registries initiating
NDI linkages should consider sharing relevant information with
death state registries to remove erroneous DCO cases in the death
state’s registry. NDI also identified a large proportion of potential
duplicate cases. Standards are needed to assign primary residence
when multiple registries report the same case. This study probably
underestimated the number of potential duplicate cases between
the FCDS and the NYSCR because the analysis was limited to de-
ceased patients.
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Tables
Table 1. Linkage of State Vital Records and National Death Index (NDI) for Cancer Patients in the Florida Cancer Data System
(FCDS) and the New York State Cancer Registry (NYSCR), 1996–2005
Category FCDS, n NYSCR, n
Cancer incident cases diagnosed 997,290 952,663
Deaths identified among incident cases 434,526 401,463
Deaths identified through linkage with state death certificate records 398,196 389,164
Died in state where diagnosis was made 398,196 383,343
Died outside of state where diagnosis was made 0 5,821
  Died in reciprocal statea 0 1,488
Deaths identified through linkage with NDI 36,330 12,299
Died in state where diagnosis was made 3,464 1,398
Died outside of state where diagnosis was made 32,866 10,901
  Died in reciprocal statea 4,657 2,740
  Died in another state 28,209 8,161
a The reciprocal state for Florida is New York, and the reciprocal state for New York is Florida.
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Table 2. Match Results Between Exchange Files and Death State Cancer Registries for Deaths of Cancer Patients in the Florida
Cancer Data System (FCDS) and the New York State Cancer Registry (NYSCR), 1996–2005
Category NYSCR, n FCDS, n
Exchange files received from reciprocal state for linkagea 4,657 2,740
Matched to a patient in registry of reciprocal stateb 3,222 1,808
Registered as a single primary DCOc incident case 233 275
Registered as non-DCOc incident case 2,989 1,533
  At least 1 record has same first 4 digits of the SEER site recode 2,512 1,248
  First 4 digits of SEER site recode are different in all records 477 285
Abbreviations: SEER, Surveillance, Epidemiology, and End Results.
a The National Death Index identified 4,657 FCDS cancer patients who died in New York and 2,740 NYSCR cancer patients who died in Florida.
b The reciprocal state for Florida is New York, and the reciprocal state for New York is Florida.
c When a state cancer registry obtains information on the death of a cancer patient through a death certificate, but no information is found in the state registry for
a cancer diagnosis, these death certificate–initiated cases are registered as death certificate–only (DCO) cases in the cancer registry’s database.
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Table 3. Matched-Case Results Among Cancer Patients Who Were Registered In Both the Florida Cancer Data System (FCDS) and
the New York State Cancer Registry (NYSCR) With One or More Similar Diagnoses, 1996–2005a
Category NYSCR and FCDS NYSCR FCDS
Total patients, n 3,760 2,512 1,248
Total non-DCOb incident cases that matched, n 4,035 2,673 1,362
Matched Cases
Cancer site
Lung and bronchus 948 (23.5) 686 (25.7) 262 (19.2)
Colorectal 472 (11.7) 296 (11.1) 176 (12.9)
Female breast 373 (9.2) 223 (8.3) 150 (11.0)
Prostate 358 (8.9) 227 (8.5) 131 (9.6)
Urinary bladder 266 (6.7) 165 (6.2) 101 (7.4)
All others 1,618 (40.1) 1,076 (40.2) 542 (39.8)
Difference in time (in months) between diagnosis dates in records of matched cases
≤6 2,970 (73.7) 2,017 (75.5) 953 (70.0)
7–12 321 (8.0) 199 (7.4) 122 (9.0)
13–24 246 (6.1) 156 (5.8) 90 (6.6)
≥25 498 (12.3) 301 (11.3) 197 (14.5)
Sequence numberc
Single primary 2,912 (72.2) 2,043 (76.4) 869 (63.8)
First primary of multiple primaries 582 (14.2) 306 (11.5) 276 (20.3)
Second or later primary of multiple primaries 541 (13.4) 324 (12.1) 217 (15.9)
a All values are number (percentage) unless otherwise indicated.
b When a state cancer registry obtains information on the death of a cancer patient through a death certificate, but no information is found in the state registry for
a cancer diagnosis, these death certificate–initiated cases are registered as death certificate–only (DCO) cases in the cancer registry’s database.
c When cancer patients are diagnosed with multiple primary cancers, each cancer case is assigned a sequence number according to the temporal order in which it
was diagnosed.
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